Panbela Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Panbela Therapeutics

10/11/2022 23:44

* Panbela Therapeutics Inc  PBLA.OQ  reported a quarterly
adjusted
loss of 21 cents​​ per share for the quarter ended in September.
The mean expectation of two analysts for the quarter was for a
loss of 22 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Panbela Therapeutics Inc's reported EPS for the quarter
was a
loss of 21 cents​.
    * The mean earnings estimate of analysts had risen by
about 5.7%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Panbela Therapeutics Inc shares had fallen by 59.3% this
quarter and lost 93.6% so far this year.
    * The company reported a quarterly loss of $4.4 million.
    * Wall Street's median 12-month price target for Panbela
Therapeutics Inc is $9.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
10 at 11:44 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.22          -0.21          Beat
 Jun. 30 2022      -0.25          -1.51          Missed
 Mar. 31 2022      -0.25          -0.27          Missed
 Dec. 31 2021      -0.18          -0.26          Missed